Compare BZAI & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BZAI | OSUR |
|---|---|---|
| Founded | 2010 | 2000 |
| Country | United States | United States |
| Employees | 254 | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.9M | 275.4M |
| IPO Year | N/A | 2000 |
| Metric | BZAI | OSUR |
|---|---|---|
| Price | $1.47 | $4.18 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $4.67 | $3.00 |
| AVG Volume (30 Days) | ★ 6.5M | 801.7K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | $239.02 | $4.48 |
| Revenue Next Year | $45.85 | $7.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $2.08 |
| 52 Week High | $6.76 | $4.33 |
| Indicator | BZAI | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 43.06 | 63.86 |
| Support Level | $1.03 | $2.93 |
| Resistance Level | $1.57 | $4.33 |
| Average True Range (ATR) | 0.16 | 0.24 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 12.73 | 76.87 |
Blaize Holdings Inc provides transformative artificial intelligence (AI)-enabled edge computing solutions comprised of both its proprietary hardware and software, and third-party hardware solutions. Its portfolio includes programmable AI processors in various form factors, which can be deployed across sectors such as smart cities, defense, retail, and enterprise markets. The company operates as a single operating and reportable segment. The majority of the company's revenue is derived from Hardware revenue, which includes the sale of its semiconductor products and/or third-party hardware products that support semiconductor products through various supply agreements. Geographically, it generates the maximum revenue from China.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.